Table 3. Pharmacokinetic Profile of MCXs 28 and 31a.
| route | parameter | 28 | 31 |
|---|---|---|---|
| I.V. | dose | 1 | 0.7 |
| AUClast | 16 596 | 11 176 | |
| T1/2 | 3.66 | 2.96 | |
| Cl | 0.060 | 0.063 | |
| Vd | 0.31 | 0.26 | |
| P.O. | dose | 10 | 5 |
| Cmax | 2929 | 9370 | |
| Tmax | 0.25 | 5 | |
| T1/2 | 23.4 | 14.6 | |
| AUClast | 58 235 | 99 055 | |
| F% | 35.08 | 124 |
PK studies. The data were adjusted to a noncompartmental model using Winnolin software. Units: Dose (mg/kg); area under the curve AUC (h.ng/mL); half-life T1/2 (h); clearance Cl (L/h/kg); volume of distribution Vd (L/kg); maximun concentration Cmax (ng/mL); time of maximum concentration Tmax (h).